Advancing Health Through Insight

Altera Brokers is a pharmaceutical brokerage and consulting firm that focuses on facilitating the acquisition, sale, and licensing of intellectual property assets while providing expert consulting services to optimize IP portfolios and strategies..


Founded in 2024 by Dr. Edward Mena alongside a group of principal industry experts who possess extensive backgrounds in clinical research, pharmaceuticals, and asset valuations, the Altera Brokers team is able to offer valuable insights into emerging pharmaceutical innovations and therapies.


Latest News

Real-World Study Accelerates Orphan Drug Approval

Our recent analysis of patient registry data reduced the evidence gap for a rare disease therapy, contributing to a six-month faster market entry.

AI-Driven Biomarker Discovery Sets New Benchmark

A collaborative project using machine-learning algorithms identified novel biomarkers that improve early diagnosis accuracy by 28%.

Global Trial Diversity Initiative Gains Momentum

We supported a multi-continent enrollment strategy that increased participant diversity, ensuring results reflect real-world populations.

Meet the Team


Our Goal

Altera Brokers' goal is to become a leading force in the pharmaceutical brokerage sector to drive advancements in pharmaceutical access, offer valuable guidance on pharmaceutical valuations that help clients optimize investments in medical resources, and improve healthcare outcomes for patients.


Let's Keep in Touch

Ready to discuss your study or need guidance on the next regulatory milestone? Reach out for a complimentary consultation and discover how evidence can work harder for you.


Contact Us

301 South Fair Oaks Avenue, Pasadena, California 91105

626-440-7325